Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 8-K, filed Sep 24, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 1070494
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 65
News 8 of 175
Prospectuses and Registrations 8 of 60
- S-8 Registration statement for an employee plan Jun 10, 2026
- S-3 Shelf registration statement May 9, 2025
- S-8 Registration statement for an employee plan Sep 23, 2024
- S-8 POS Post-effective amendment to an employee plan registration Aug 20, 2024
- S-8 POS Post-effective amendment to an employee plan registration Aug 20, 2024
- S-8 POS Post-effective amendment to an employee plan registration Aug 20, 2024
- S-8 POS Post-effective amendment to an employee plan registration Aug 20, 2024
- S-8 POS Post-effective amendment to an employee plan registration Aug 20, 2024
Proxies 8 of 24
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
- DEFR14A May 13, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2022
- DEFR14A May 12, 2021
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2021
Ownership 8 of 637
- 4 Insider reported a trade Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 144 Notice of a proposed sale of restricted stock Aug 5, 2026
- 4 Insider reported a trade Jul 31, 2026
- 4 Insider reported a trade Jun 29, 2026
- 144 Notice of a proposed sale of restricted stock Jun 26, 2026
- 4 Insider reported a trade Jun 2, 2026
- 4 Insider reported a trade Jun 1, 2026
Other 8 of 41
- ARS Annual report sent to shareholders Apr 24, 2026
- EFFECT Notice that a registration became effective May 23, 2025
- CORRESP Reply to SEC staff May 21, 2025
- UPLOAD Comment letter from SEC staff May 14, 2025
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders May 1, 2023
- CT ORDER May 4, 2022
Everything here comes from Acadia Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.